| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 18.56M | $1.28B | - | |
| 10% | 14.59M | $1.01B | - | |
| CEO | 4.40M | $303.14M | - | |
| Dir | 916.7K | $63.18M | - | |
| Dir | 766.6K | $52.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2020 | Kumar Neil | CEO And President | Sell | 5,930 | $30.05 | $178,173.37 | -0.3% | |
| Jun 1, 2020 | Kumar Neil | CEO And President | Sell | 80,000 | $29.19 | $2,335,389.61 | -1.7% | |
| Jun 1, 2020 | Stephenson Brian C | See Remarks | Sell | 7,200 | $29.36 | $211,400.91 | -1.2% | |
| Jun 1, 2020 | Henderson Michael Thomas58 | Chief Business Officer | Sell | 2,585 | $29.37 | $75,911.65 | -0.5% | |
| May 5, 2020 | Stephenson Brian C | See Remarks | Sell | 5,706 | $30.49 | $173,959.39 | -1.8% | |
| May 5, 2020 | Henderson Michael Thomas58 | See Remarks | Sell | 1,460 | $30.47 | $44,493.35 | -0.9% | |
| May 5, 2020 | Kumar Neil | CEO And President | Sell | 79,600 | $31.02 | $2,469,481.93 | -1.6% | |
| May 4, 2020 | Stephenson Brian C | See Remarks | Sell | 8,694 | $29.37 | $255,301.53 | -0.9% | |
| May 4, 2020 | Kumar Neil | CEO And President | Sell | 80,400 | $29.40 | $2,364,085.00 | -0.8% | |
| May 4, 2020 | Henderson Michael Thomas58 | See Remarks | Sell | 3,905 | $29.52 | $115,266.78 | -0.8% |